United States Fabry Disease Treatment Research Report 2024: Market Size, Trends, Competition, Forecasts and Opportunities, 2019-2029
August 27, 2024 10:09 ET
|
Research and Markets
Dublin, Aug. 27, 2024 (GLOBE NEWSWIRE) -- The "United States Fabry Disease Treatment Market, By Region, Competition, Forecast and Opportunities, 2019-2029F" report has been added to ...
Fabry Disease Treatment Market: Comprehensive Insights and Growth Projections for 2024-2030
February 14, 2024 16:36 ET
|
Research and Markets
Dublin, Feb. 14, 2024 (GLOBE NEWSWIRE) -- The "Global Fabry Disease Treatment Market by Treatment Type (Chaperone Treatment, Enzyme Replacement Therapy, Organ-Specific Treatment), Drugs (Agalsidase...
Fabry Disease Treatment Market Size Projections Indicate a CAGR of 7.26%, Envisioned to Attain a Value of USD 3342.65 Million by 2030
October 02, 2023 16:01 ET
|
Zion Market Research
NEW YORK, United States, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “Fabry Disease Treatment Market By Treatment (Substrate Reduction Therapy,...
Fabry Disease Epidemiology and Market Trends to 2030
January 24, 2022 04:58 ET
|
Research and Markets
Dublin, Jan. 24, 2022 (GLOBE NEWSWIRE) -- The "Fabry Disease- Market Insight, Epidemiology and Market Forecast -2030" report has been added to ResearchAndMarkets.com's offering. The report...
Global Fabry Disease Treatment Market Size Value Surges to Record USD 3.78 Billion by 2026: Facts & Factors
April 16, 2021 09:28 ET
|
Facts & Factors
New York, NY, April 16, 2021 (GLOBE NEWSWIRE) -- Facts and Factors have published a new research report titled “Fabry Disease Treatment Market by Drugs (Agalsidase Beta, Migalastat, and Pipeline...